BamSEC and AlphaSense Join Forces
Learn More

Prothena Corporation plc

NASDAQ: PRTA    
Share price (1/8/25): $14.16    
Market cap (1/8/25): $762 million
Search in Documents
Key Exhibits
External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

EX-2
from SC 13D/A ~5 pages Joint Filing Agreement
12/34/56
EX-2.2(B)
from S-1/A 3 pages Amendment Number One Amended and Restated Intellectual Property License and Contribution Agreement
12/34/56
EX-2
from SC 13D 1 page Joint Filing Agreement
12/34/56
EX-2.3
from 8-K 4 pages Asset Purchase Agreement
12/34/56
EX-2.2
from 8-K 11 pages Intellectual Property License and Conveyance Agreement Among Neotope Biosciences Limited and Elan Pharma International Limited and Elan Pharmaceuticals, Inc. Dated as of December 20, 2012 1 Intellectual Property License and Conveyance Agreement
12/34/56
EX-2.1
from 8-K 12 pages Amended and Restated Intellectual Property License and Contribution Agreement Among Neotope Biosciences Limited and Elan Pharma International Limited and Elan Pharmaceuticals, Inc. Dated as of December 20, 2012 1 Amended and Restated Intellectual Property License and Contribution Agreement
12/34/56
EX-2.3
from 10-12B/A 11 pages Intellectual Property License and Conveyance Agreement Among Neotope Biosciences Limited and Elan Pharma International Limited and Elan Pharmaceuticals, Inc. Dated as of December , 2012 1 Intellectual Property License and Conveyance Agreement
12/34/56
EX-2.4
from 10-12B/A 4 pages Asset Purchase Agreement
12/34/56
EX-2.3
from 10-12B/A 11 pages Intellectual Property License and Conveyance Agreement Among Neotope Biosciences Limited and Elan Pharma International Limited and Elan Pharmaceuticals, Inc. Dated as of December , 2012 1 Intellectual Property License and Conveyance Agreement
12/34/56
EX-2.2
from 10-12B/A 12 pages Amended and Restated Intellectual Property License and Contribution Agreement Among Neotope Biosciences Limited and Elan Pharma International Limited and Elan Pharmaceuticals, Inc. Dated as of December , 2012 1 Amended and Restated Intellectual Property License and Contribution Agreement
12/34/56
EX-2.1
from 10-12B/A 50 pages Dated 8 November 2012 Elan Corporation, PLC and Prothena Corporation plc Demerger Agreement Contents
12/34/56